Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by LadRx Corporation

LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates
From LadRx Corporation
Via Business Wire
Tickers LADX
LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License
From LadRx Corporation
Via Business Wire
Tickers LADX
LadRx Issues 2024 Update to Shareholders
From LadRx Corporation
Via Business Wire
Tickers LADX
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation
From LadRx Corporation
Via Business Wire
Tickers LADX
LadRx Announces Reverse Stock Split Effective as of May 17, 2023
From LadRx Corporation
Via Business Wire
Tickers LADX
LadRx Announces Reverse Stock Split
From LadRx Corporation
Via Business Wire
Tickers LADX
LadRx Highlights Patent Issued for Its LADR Technology
From LadRx Corporation
Via Business Wire
Tickers LADX
LadRx Announces Review of Strategic Alternatives and Provides Corporate Updates
From LadRx Corporation
Via Business Wire
Tickers LADX
LadRx Corporation Issues Corporate Update for 3Q22
From LadRx Corporation
Via Business Wire
Tickers LADX
LadRx Corporation Announces OTCQB Ticker Change to LADX
From LadRx Corporation
Via Business Wire
Tickers CYTR
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.